Canopy Growth (TSE:WEED) Price Target Lowered to C$3.20 at ATB Capital

Canopy Growth (TSE:WEEDFree Report) had its price objective decreased by ATB Capital from C$4.00 to C$3.20 in a research note published on Monday morning,BayStreet.CA reports. ATB Capital currently has an underperform rating on the stock.

Separately, Canaccord Genuity Group decreased their price objective on shares of Canopy Growth from C$2.50 to C$1.50 and set a “sell” rating for the company in a research note on Monday. Four analysts have rated the stock with a sell rating and one has assigned a hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Reduce” and a consensus target price of C$5.40.

Check Out Our Latest Stock Report on Canopy Growth

Canopy Growth Stock Performance

Shares of WEED stock opened at C$2.56 on Monday. The company has a debt-to-equity ratio of 117.00, a current ratio of 2.15 and a quick ratio of 2.32. The firm has a 50-day moving average of C$3.77 and a 200-day moving average of C$5.90. Canopy Growth has a one year low of C$2.50 and a one year high of C$20.50. The company has a market cap of C$217.24 million, a P/E ratio of -0.32, a P/E/G ratio of -0.01 and a beta of 1.79.

Canopy Growth Company Profile

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names.

Featured Articles

Analyst Recommendations for Canopy Growth (TSE:WEED)

Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with MarketBeat.com's FREE daily email newsletter.